William S. White
Direttore operativo presso Nemucore Medical Innovations, Inc.
Posizioni attive di William S. White
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Direttore operativo | - | - |
Storia della carriera di William S. White
Precedenti posizioni note di William S. White
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Biocache Pharmaceuticals, Inc. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
The Virginia Biotechnology Research Park
 The Virginia Biotechnology Research Park Real Estate DevelopmentFinance The Virginia Biotechnology Research Park operates a pharmaceutical and biotechnology corridor. The private company is based in Richmond, VA. Chandra Briggman has been the CEO of the company since 2020. | Direttore/Membro del Consiglio | - | - |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Direttore/Membro del Consiglio | - | - |
| CropTech Corp. | Direttore/Membro del Consiglio | - | 10/11/2011 |
| Presidente | 10/11/2011 | - | |
| MONSANTO | Presidente | - | - |
| Storz Ophthalmics, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
Icon Bioscience, Inc.
 Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Director/Board Member | 5 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 3 |
| Distribution Services | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 7 |
|---|---|
Icon Bioscience, Inc.
Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Health Technology |
| Storz Ophthalmics, Inc. | |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
| CropTech Corp. | |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
| Biocache Pharmaceuticals, Inc. | |
The Virginia Biotechnology Research Park
The Virginia Biotechnology Research Park Real Estate DevelopmentFinance The Virginia Biotechnology Research Park operates a pharmaceutical and biotechnology corridor. The private company is based in Richmond, VA. Chandra Briggman has been the CEO of the company since 2020. | Finance |
- Borsa valori
- Insiders
- William S. White
- Esperienza
